118 related articles for article (PubMed ID: 6248368)
1. Demonstration of specific receptors for EGF--urogastrone in isolated rat intestinal epithelial cells.
Forgue-Lafitte ME; Laburthe M; Chamblier MC; Moody AJ; Rosselin G
FEBS Lett; 1980 Jun; 114(2):243-6. PubMed ID: 6248368
[No Abstract] [Full Text] [Related]
2. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts.
Hollenberg MD; Gregory H
Life Sci; 1977 Jan; 20(2):267-74. PubMed ID: 190507
[No Abstract] [Full Text] [Related]
3. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites.
Prieto JC; Laburthe M; Rosselin G
Eur J Biochem; 1979 May; 96(2):229-37. PubMed ID: 37084
[No Abstract] [Full Text] [Related]
4. Epidermal growth factor-urogastrone receptor: selective alteration in simian virus 40 transformed mouse fibroblasts.
Berhanu P; Hollenberg MD
Arch Biochem Biophys; 1980 Aug; 203(1):134-44. PubMed ID: 6250481
[No Abstract] [Full Text] [Related]
5. No effect of starvation on vasoactive intestinal peptide (VIP) receptors in intestinal epithelial cells.
Prieto JC; Guerrero JM; Goberna R
Horm Metab Res; 1980 May; 12(5):223-4. PubMed ID: 6248446
[No Abstract] [Full Text] [Related]
6. Selective reduction in receptors for epidermal growth factor-urogastrone in chemically transformed tumorigenic Syrian hamster embryo fibroblasts.
Hollenberg MD; Barrett JC; Ts'o PO; Berhanu P
Cancer Res; 1979 Oct; 39(10):4166-9. PubMed ID: 225016
[No Abstract] [Full Text] [Related]
7. Isolation of the human placenta receptor for epidermal growth factor-urogastrone.
Hock RA; Nexø E; Hollenberg MD
Nature; 1979 Feb; 277(5695):403-5. PubMed ID: 233121
[No Abstract] [Full Text] [Related]
8. Insulin and epidermal growth factor-urogastrone: affinity crosslinking to specific binding sites in rat liver membranes.
Sahyoun N; Hock RA; Hollenberg MD
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1675-9. PubMed ID: 205865
[TBL] [Abstract][Full Text] [Related]
9. Receptors for insulin and epidermal growth factor-urogastrone in adult human fibroblasts do not change with donor age.
Hollenberg MD; Schneider EL
Mech Ageing Dev; 1979 Aug; 11(1):37-43. PubMed ID: 226815
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptor for epidermal growth factor-urogastrone in human placenta membranes.
Hock RA; Hollenberg MD
J Biol Chem; 1980 Nov; 255(22):10731-6. PubMed ID: 6253485
[TBL] [Abstract][Full Text] [Related]
11. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development.
Nexø E; Hollenberg MD; Figueroa A; Pratt RM
Proc Natl Acad Sci U S A; 1980 May; 77(5):2782-5. PubMed ID: 6248866
[TBL] [Abstract][Full Text] [Related]
12. Interaction of epidermal growth factor with specific binding sites of enterocytes isolated from rat small intestine during development.
Toyoda S; Lee PC; Lebenthal E
Biochim Biophys Acta; 1986 Apr; 886(2):295-301. PubMed ID: 3008854
[TBL] [Abstract][Full Text] [Related]
13. Lectin-agarose immobilization, a new method for detecting soluble membrane receptors. Application to studies with epidermal growth factor-urogastrone and transcobalamin-II.
Nexł E; Hock RA; Hollenberg MD
J Biol Chem; 1979 Sep; 254(18):8740-3. PubMed ID: 314449
[No Abstract] [Full Text] [Related]
14. Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase.
Hirata Y; Orth DN
J Clin Endocrinol Metab; 1979 Sep; 49(3):481-3. PubMed ID: 313937
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone.
Hock RA; Nexø E; Hollenberg MD
J Biol Chem; 1980 Nov; 255(22):10737-43. PubMed ID: 6253486
[TBL] [Abstract][Full Text] [Related]
16. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a polypeptide that enhances cellular binding of epidermal growth factor.
Deo MG; Mulherkar R; Mane SM
Indian J Biochem Biophys; 1983 Aug; 20(4):228-31. PubMed ID: 6323306
[No Abstract] [Full Text] [Related]
18. Epidermal growth factor receptor number decreases during rat liver regeneration.
Earp HS; O'Keefe EJ
J Clin Invest; 1981 May; 67(5):1580-3. PubMed ID: 6262381
[TBL] [Abstract][Full Text] [Related]
19. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
[TBL] [Abstract][Full Text] [Related]
20. Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine.
Blay J; Brown KD
Biochem J; 1985 Jan; 225(1):85-94. PubMed ID: 2983665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
